bioseparation


Also found in: Acronyms.

bioseparation

[‚bī·ō‚sep·ə′rā·shən]
(biochemistry)
The recovery of a product from solutions of cells and media; the process used must avoid harsh conditions that could damage the product.
References in periodicals archive ?
Bioseparation Processes Used for Biologics Manufacturing
To order this report: Bioseparation Systems for Global Biopharmaceutical Markets http://www.
With decades of critical application experience and a global, knowledgeable technical sales team dedicated to high-level service, Purolite is positioned to provide bioseparation resins that meet the most stringent demands for biotechnological research and applications.
Since then he has been a professor in the Department of Chemical Engineering at the University of Virginia, Charlottesville (USA), where his research focuses on transport phenomena and bioseparations.
The competitive landscape section of this report covers information on Strategy, Bioseparations Product Mix and Brands, Platforms and Product Groups, Process Development and Technical Support as well as New product launches for companies like GE Healthcare Life Sciences, Merck Millipore, Pall Corporation, Sartorius and 3M CUNO.
To order this report: Biopharmaceutical Industry : Bioseparation Systems for Global Biopharmaceutical Markets
This new partnership brings added recognition to ProMetic's expertise and further consolidates our position as a leading provider of innovative bioseparation solutions to the biopharmaceutical industry," said Dr.
Andras Guttman, Marie Curie Chair of the European Commission, head of the HorvEith Laboratory of Bioseparation Sciences in the University in Innsbruck, Austria.
SV) announced today that it has received the Frost & Sullivan 2004 Bioseparation Technology Leadership Award for its sustained technological leadership in the bioseparation sector.
announced today the signing of a collaboration agreement utilizing bioseparation systems to recover proteins from human blood plasma, between Sartorius and ProMetic's subsidiary ProMetic BioTherapeutics, Inc.
will accelerate development of bioseparation products based on applications of its unique and proprietary Mimetic Ligand(TM) technology.
Karin Bronnenmeier, Linde-KCA-Dresden GmbH- "Systematic Design and Construction of Biotech and Pharmaceutical Plants" Miriam Monge and Jan Eric Zandbergen, Stedium SA - "Disposable Technologies for Aseptic Filling - a case study" Uwe Gottschalk, Sartorius- "Faster, Cheaper, Purer: Requirements of Modern Bioseparation Processes" Anders Vinther, CMC BioPharmaceuticals- "Quality Reflections over Qualification of a State-of-the-Art Contract Manufacturing Facility" Ian Sellick, Pall Life Sciences- "From High-speed Miniaturized Process Optimization to High-speed Purification Processes" Linda F.